• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2022年甲状腺结节管理共识:SFE-AFCE-SFMN关于甲状腺结节的初始检查》

SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: Initial work-up for thyroid nodules.

作者信息

Do Cao Christine, Haissaguerre Magalie, Lussey-Lepoutre Charlotte, Donatini Gianluca, Raverot Véronique, Russ Gilles

机构信息

Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, CHU Lille, Lille, France.

Department of Endocrinology and Endocrine Oncology, Haut Lévêque Hospital, Bordeaux University Hospital, Pessac, France.

出版信息

Ann Endocrinol (Paris). 2022 Dec;83(6):380-388. doi: 10.1016/j.ando.2022.10.009. Epub 2022 Oct 21.

DOI:10.1016/j.ando.2022.10.009
PMID:36280193
Abstract

The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). This section deals with the initial work-up for thyroid nodules in adult patients, including clinical and biological evaluation, standardized ultrasound characterization and EU-TIRADS-based nodule selection for fine-needle aspiration biopsy. Indications for thyroid core-biopsies or open surgical biopsies and for cross-sectional imaging of the neck and upper chest are also mentioned.

摘要

《2022年法国内分泌学会-法国内分泌外科学会-法国核医学学会关于甲状腺结节管理的共识》涉及甲状腺结节的管理,甲状腺结节是内分泌科常见的就诊原因。在超过90%的病例中,患者甲状腺功能正常,结节为良性且无进展,无需特殊治疗。临床医生的目标是检测出有复发和死亡风险的恶性甲状腺结节、导致甲状腺功能亢进的毒性结节或需要治疗的压迫性结节。甲状腺结节的诊断和治疗需要内分泌科医生、核医学医生和外科医生密切合作,但也涉及其他专科医生。因此,本共识声明由3个学会联合制定:法国内分泌学会(SFE)、法国内分泌外科学会(AFCE)和法国核医学学会(SFMN);各个工作组包括来自其他专科(病理学家、放射科医生、儿科医生、生物学家等)的专家。本节讨论成年患者甲状腺结节的初始检查,包括临床和生物学评估、标准化超声特征描述以及基于欧盟甲状腺影像报告和数据系统(EU-TIRADS)的细针穿刺活检结节选择。还提到了甲状腺粗针活检或开放手术活检以及颈部和上胸部横断面成像的适应证。

相似文献

1
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: Initial work-up for thyroid nodules.《2022年甲状腺结节管理共识:SFE-AFCE-SFMN关于甲状腺结节的初始检查》
Ann Endocrinol (Paris). 2022 Dec;83(6):380-388. doi: 10.1016/j.ando.2022.10.009. Epub 2022 Oct 21.
2
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Recommendations in thyroid cytology: from technique to interpretation.SFE-AFCE-SFMN 2022甲状腺结节管理共识:甲状腺细胞病理学建议:从技术到解读
Ann Endocrinol (Paris). 2022 Dec;83(6):389-394. doi: 10.1016/j.ando.2022.10.004. Epub 2022 Oct 23.
3
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Epidemiology and challenges in the management of thyroid nodules.《2022年甲状腺结节管理的SFE-AFCE-SFMN共识:甲状腺结节管理中的流行病学及挑战》
Ann Endocrinol (Paris). 2022 Dec;83(6):378-379. doi: 10.1016/j.ando.2022.10.003. Epub 2022 Oct 23.
4
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Follow-up: How and how long?《2022年甲状腺结节管理的SFE-AFCE-SFMN共识:随访:方式及时长?》
Ann Endocrinol (Paris). 2022 Dec;83(6):407-414. doi: 10.1016/j.ando.2022.10.010. Epub 2022 Oct 23.
5
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Thyroid nodules and pregnancy.SFE-AFCE-SFMN 2022甲状腺结节管理共识:甲状腺结节与妊娠
Ann Endocrinol (Paris). 2022 Dec;83(6):435-439. doi: 10.1016/j.ando.2022.10.005. Epub 2022 Oct 19.
6
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Thyroid nodules in children.《2022年儿童甲状腺结节管理的SFE-AFCE-SFMN共识》 :儿童甲状腺结节
Ann Endocrinol (Paris). 2022 Dec;83(6):431-434. doi: 10.1016/j.ando.2022.10.007. Epub 2022 Oct 23.
7
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodules.SFE-AFCE-SFMN 2022甲状腺结节管理共识:分子检测在甲状腺细针穿刺结果不确定结节中的作用
Ann Endocrinol (Paris). 2022 Dec;83(6):395-400. doi: 10.1016/j.ando.2022.10.006. Epub 2022 Oct 23.
8
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules: Introduction to the consensus.《2022年甲状腺结节管理的SFE-AFCE-SFMN共识:共识介绍》
Ann Endocrinol (Paris). 2022 Dec;83(6):375-377. doi: 10.1016/j.ando.2022.10.002. Epub 2022 Oct 23.
9
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Surgical treatment.《2022年甲状腺结节管理的SFE-AFCE-SFMN共识:手术治疗》
Ann Endocrinol (Paris). 2022 Dec;83(6):415-422. doi: 10.1016/j.ando.2022.10.012. Epub 2022 Oct 26.
10
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Synthesis and algorithms.《2022年甲状腺结节管理的SFE-AFCE-SFMN共识:综合与算法》
Ann Endocrinol (Paris). 2022 Dec;83(6):440-453. doi: 10.1016/j.ando.2022.11.001. Epub 2022 Nov 4.

引用本文的文献

1
2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma.2025年韩国甲状腺协会低风险乳头状甲状腺癌主动监测临床管理指南
Endocrinol Metab (Seoul). 2025 Jun;40(3):307-341. doi: 10.3803/EnM.2025.2461. Epub 2025 Jun 24.
2
Ultrasound Imaging Criteria and Protocols for Active Surveillance of Low-Risk Thyroid Cancer: A Review of International Consensus Guidelines.低风险甲状腺癌主动监测的超声成像标准与方案:国际共识指南综述
Endocrinol Metab (Seoul). 2025 Apr;40(2):185-194. doi: 10.3803/EnM.2024.2319. Epub 2025 Mar 27.
3
Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement.
成人低风险甲状腺微小癌主动监测的标准化超声评估:2024年韩国甲状腺放射学会共识声明
J Korean Soc Radiol. 2024 Nov;85(6):1060-1082. doi: 10.3348/jksr.2024.0132. Epub 2024 Nov 15.
4
Evaluation of the clinical efficacy of microwave ablation for benign thyroid nodules based on contrast-enhanced ultrasound.基于超声造影评估微波消融治疗良性甲状腺结节的临床疗效
Medicine (Baltimore). 2024 Dec 6;103(49):e40774. doi: 10.1097/MD.0000000000040774.
5
Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement.成人低危甲状腺微小癌主动监测的标准化超声评估:2024 年韩国甲状腺放射学会共识声明。
Korean J Radiol. 2024 Nov;25(11):942-958. doi: 10.3348/kjr.2024.0871.
6
Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines.主动监测低危甲状腺癌:当前实践指南综述。
Endocrinol Metab (Seoul). 2024 Feb;39(1):47-60. doi: 10.3803/EnM.2024.1937. Epub 2024 Feb 15.